Kooi GS - Search Results

1

Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review.

Gerestein CG, Damhuis RA, Burger CW, Kooi GS. Gerestein CG, et al. Among authors: kooi gs. Gynecol Oncol. 2009 Sep;114(3):523-7. doi: 10.1016/j.ygyno.2009.03.011. Epub 2009 Apr 2. Gynecol Oncol. 2009. PMID: 19344936 Review.

2

Prediction of residual disease after primary cytoreductive surgery for advanced-stage ovarian cancer: accuracy of clinical judgment.

Gerestein CG, van der Spek DW, Eijkemans MJ, Bakker J, Kooi GS, Burger CW. Gerestein CG, et al. Among authors: kooi gs. Int J Gynecol Cancer. 2009 Dec;19(9):1511-5. doi: 10.1111/IGC.0b013e3181bf82be. Int J Gynecol Cancer. 2009. PMID: 19955927 Clinical Trial.

3

Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer.

Gerestein CG, Eijkemans MJ, Bakker J, Elgersma OE, van der Burg ME, Kooi GS, Burger CW. Gerestein CG, et al. Among authors: kooi gs. Anticancer Res. 2011 Nov;31(11):4043-9. Anticancer Res. 2011. PMID: 22110240

4

Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma.

de Jong D, Eijkemans MJ, Lie Fong S, Gerestein CG, Kooi GS, Baalbergen A, van der Burg ME, Burger CW, Ansink AC. de Jong D, et al. Among authors: kooi gs. Oncology. 2007;72(5-6):293-301. doi: 10.1159/000113051. Epub 2008 Jan 14. Oncology. 2007. PMID: 18198490

5

The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma.

Gerestein CG, Eijkemans MJ, de Jong D, van der Burg ME, Dykgraaf RH, Kooi GS, Baalbergen A, Burger CW, Ansink AC. Gerestein CG, et al. Among authors: kooi gs. BJOG. 2009 Feb;116(3):372-80. doi: 10.1111/j.1471-0528.2008.02033.x. BJOG. 2009. PMID: 19187369

6

Causes of postoperative mortality after surgery for ovarian cancer.

Gerestein CG, Damhuis RA, de Vries M, Reedijk A, Burger CW, Kooi GS. Gerestein CG, et al. Among authors: kooi gs. Eur J Cancer. 2009 Nov;45(16):2799-803. doi: 10.1016/j.ejca.2009.06.004. Epub 2009 Jul 15. Eur J Cancer. 2009. PMID: 19615887

7

Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.

Gerestein CG, Nieuwenhuyzen-de Boer GM, Eijkemans MJ, Kooi GS, Burger CW. Gerestein CG, et al. Among authors: kooi gs. Eur J Cancer. 2010 Jan;46(1):102-9. doi: 10.1016/j.ejca.2009.10.017. Eur J Cancer. 2010. PMID: 19900801

8

Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.

Nieuwenhuyzen-de Boer GM, Gerestein CG, Eijkemans MJ, Burger CW, Kooi GS. Nieuwenhuyzen-de Boer GM, et al. Among authors: kooi gs. Eur J Gynaecol Oncol. 2016;37(1):63-8. Eur J Gynaecol Oncol. 2016. PMID: 27048112

9

Inadequate office endometrial sample requires further evaluation in women with postmenopausal bleeding and abnormal ultrasound results.

van Doorn HC, Opmeer BC, Burger CW, Duk MJ, Kooi GS, Mol BW; Dutch Study in Postmenopausal Bleeding (DUPOMEB). van Doorn HC, et al. Among authors: kooi gs. Int J Gynaecol Obstet. 2007 Nov;99(2):100-4. doi: 10.1016/j.ijgo.2007.05.040. Epub 2007 Sep 24. Int J Gynaecol Obstet. 2007. PMID: 17889875

10

Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen.

Klaassens AH, van Wijk FH, Hanifi-Moghaddam P, Sijmons B, Ewing PC, Ten Kate-Booij MJ, Kooi GS, Kloosterboer HJ, Blok LJ, Burger CW. Klaassens AH, et al. Among authors: kooi gs. Fertil Steril. 2006 Aug;86(2):352-61. doi: 10.1016/j.fertnstert.2005.12.077. Epub 2006 Jul 7. Fertil Steril. 2006. PMID: 16828477 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page